Central Serous Chorioretinopathy: Etiology, Course and Prognosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-04-30

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with established ophthalmologic methods (multimodal imagine) every 6 weeks until subretinal fluid is reabsorbed to gain further insides in etiology, course and prognosis of this disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Central Serous Chorioretinopathy Registry and Pachychoroid Observation and Natural History Study

NCT05278169

Central Serous Chorioretinopathy

UNKNOWN

Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

NCT01610804

Choroidal Thickness

COMPLETED

Green Subthreshold Laser Therapy for Chronic Central Serous Chorioretinopathy.

NCT07020793

the Presence of Subretinal Fluid (SRF)

COMPLETED

Retrospective Analysis of the Clinical Characteristics of Retinal Vein Occlusion

NCT06757595

Retinal Vein Occlusion

COMPLETED

Optical Coherence Tomography Angiography (OCT-A) and Central Serous Chorioretinopathy (CSC)

NCT03950089

Central Serous Chorioretinopathy

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with central serous chorioretinopathy are recruited from the Department of Ophthalmology at the Medical University of Vienna. All patients undergo ETDRS visual acuity measurement, Pelli-Robson contrast examination, Amsler-Grid testing, questionnaire testing, ophthalmologic examination, SD-OCT and polarization-sensitive OCT, fundus autofluorescence, fluorescein angiography, indocyanine-green angiography, fundus photo and microperimetry. Patients are re-examined after an interval of 6 weeks until subretinal fluid is entirely reabsorbed to gain further insides in etiology, course and prognosis of this disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Serous Chorioretinopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent form
* Age over 18 years
* acute episode of Central Serous Chorioretinopathy
* Symptoms for less than two weeks
* no treatment on study eye